Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years: Millennium cohort study

Caroline Delahunty, Shona Falconer, Robert Hume, Lesley Jackson, Paula Midgley, Marie Mirfield, Simon Ogston, Oliver Perra, Judith Simpson, Jennifer Watson, Peter Willatts, Fiona Williams, Jackie Dunlop, Sheena Kinmond, David Lloyd, Una McFadyen, Ann McArthur, Sheena Mitchell, Mary Ray, Ann Vallance

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Context: Transient hypothyroxinemia is the commonest thyroid dysfunction of premature infants, and recent studies have found adverse associations with neurodevelopment. The validity of these associations is unclear because the studies adjusted for a differing range of factors likely to influence neurodevelopment. Objective: The aim was to describe the association of transient hypothyroxinemia with neurodevelopment at 5.5 yr corrected age. Design: We conducted a follow-up study of a cohort of infants born in Scotland from 1999 to 2001 ≤34 wk gestation. Main Outcome Measures: We measured scores on the McCarthy scale adjusted for 26 influences of neurodevelopment including parental intellect, home environment, breast or formula fed, growth retardation, and use of postnatal drugs. Results: A total of 442 infants ≤34 wk gestation who had serum T4 measurements on postnatal d 7, 14, or 28 and 100 term infants who had serum T4 measured in cord blood were followed up at 5.5 yr. Infants with hypothyroxinemia (T4 level ≤ 10th percentile on d 7, 14, or 28 corrected for gestational age) scored significantly lower than euthyroid infants (T4 level greater than the 10th percentile and less than the 90th percentile on all days) on all McCarthy scales, except the quantitative. After adjustment for confounders of neurodevelopment, hypothyroxinemic infants scored significantly lower than euthyroid infants on the general cognitive and verbal scales. Conclusions: Our findings do not support the view that the hypothyroxinemic state, in the context of this analysis, is harmless in preterm infants. Many factors contribute both to the etiology of hypothyroxinemia and neurodevelopment; strategies for correction of hypothyroxinemia should acknowledge its complex etiology and not rely solely on one approach.

Original languageEnglish (US)
Pages (from-to)4898-4908
Number of pages11
JournalJournal of Clinical Endocrinology and Metabolism
Volume95
Issue number11
DOIs
StatePublished - Nov 2010

Fingerprint

Thyroid Hormones
Premature Infants
Cohort Studies
Blood
Pharmaceutical Preparations
Pregnancy
Scotland
Serum
Fetal Blood
Gestational Age
Thyroid Gland
Breast
Outcome Assessment (Health Care)
Growth

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years : Millennium cohort study. / Delahunty, Caroline; Falconer, Shona; Hume, Robert; Jackson, Lesley; Midgley, Paula; Mirfield, Marie; Ogston, Simon; Perra, Oliver; Simpson, Judith; Watson, Jennifer; Willatts, Peter; Williams, Fiona; Dunlop, Jackie; Kinmond, Sheena; Lloyd, David; McFadyen, Una; McArthur, Ann; Mitchell, Sheena; Ray, Mary; Vallance, Ann.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 11, 11.2010, p. 4898-4908.

Research output: Contribution to journalArticle

Delahunty, C, Falconer, S, Hume, R, Jackson, L, Midgley, P, Mirfield, M, Ogston, S, Perra, O, Simpson, J, Watson, J, Willatts, P, Williams, F, Dunlop, J, Kinmond, S, Lloyd, D, McFadyen, U, McArthur, A, Mitchell, S, Ray, M & Vallance, A 2010, 'Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years: Millennium cohort study', Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 11, pp. 4898-4908. https://doi.org/10.1210/jc.2010-0743
Delahunty, Caroline ; Falconer, Shona ; Hume, Robert ; Jackson, Lesley ; Midgley, Paula ; Mirfield, Marie ; Ogston, Simon ; Perra, Oliver ; Simpson, Judith ; Watson, Jennifer ; Willatts, Peter ; Williams, Fiona ; Dunlop, Jackie ; Kinmond, Sheena ; Lloyd, David ; McFadyen, Una ; McArthur, Ann ; Mitchell, Sheena ; Ray, Mary ; Vallance, Ann. / Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years : Millennium cohort study. In: Journal of Clinical Endocrinology and Metabolism. 2010 ; Vol. 95, No. 11. pp. 4898-4908.
@article{2d5c0e0ac7704adaa150044965645d9f,
title = "Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years: Millennium cohort study",
abstract = "Context: Transient hypothyroxinemia is the commonest thyroid dysfunction of premature infants, and recent studies have found adverse associations with neurodevelopment. The validity of these associations is unclear because the studies adjusted for a differing range of factors likely to influence neurodevelopment. Objective: The aim was to describe the association of transient hypothyroxinemia with neurodevelopment at 5.5 yr corrected age. Design: We conducted a follow-up study of a cohort of infants born in Scotland from 1999 to 2001 ≤34 wk gestation. Main Outcome Measures: We measured scores on the McCarthy scale adjusted for 26 influences of neurodevelopment including parental intellect, home environment, breast or formula fed, growth retardation, and use of postnatal drugs. Results: A total of 442 infants ≤34 wk gestation who had serum T4 measurements on postnatal d 7, 14, or 28 and 100 term infants who had serum T4 measured in cord blood were followed up at 5.5 yr. Infants with hypothyroxinemia (T4 level ≤ 10th percentile on d 7, 14, or 28 corrected for gestational age) scored significantly lower than euthyroid infants (T4 level greater than the 10th percentile and less than the 90th percentile on all days) on all McCarthy scales, except the quantitative. After adjustment for confounders of neurodevelopment, hypothyroxinemic infants scored significantly lower than euthyroid infants on the general cognitive and verbal scales. Conclusions: Our findings do not support the view that the hypothyroxinemic state, in the context of this analysis, is harmless in preterm infants. Many factors contribute both to the etiology of hypothyroxinemia and neurodevelopment; strategies for correction of hypothyroxinemia should acknowledge its complex etiology and not rely solely on one approach.",
author = "Caroline Delahunty and Shona Falconer and Robert Hume and Lesley Jackson and Paula Midgley and Marie Mirfield and Simon Ogston and Oliver Perra and Judith Simpson and Jennifer Watson and Peter Willatts and Fiona Williams and Jackie Dunlop and Sheena Kinmond and David Lloyd and Una McFadyen and Ann McArthur and Sheena Mitchell and Mary Ray and Ann Vallance",
year = "2010",
month = "11",
doi = "10.1210/jc.2010-0743",
language = "English (US)",
volume = "95",
pages = "4898--4908",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years

T2 - Millennium cohort study

AU - Delahunty, Caroline

AU - Falconer, Shona

AU - Hume, Robert

AU - Jackson, Lesley

AU - Midgley, Paula

AU - Mirfield, Marie

AU - Ogston, Simon

AU - Perra, Oliver

AU - Simpson, Judith

AU - Watson, Jennifer

AU - Willatts, Peter

AU - Williams, Fiona

AU - Dunlop, Jackie

AU - Kinmond, Sheena

AU - Lloyd, David

AU - McFadyen, Una

AU - McArthur, Ann

AU - Mitchell, Sheena

AU - Ray, Mary

AU - Vallance, Ann

PY - 2010/11

Y1 - 2010/11

N2 - Context: Transient hypothyroxinemia is the commonest thyroid dysfunction of premature infants, and recent studies have found adverse associations with neurodevelopment. The validity of these associations is unclear because the studies adjusted for a differing range of factors likely to influence neurodevelopment. Objective: The aim was to describe the association of transient hypothyroxinemia with neurodevelopment at 5.5 yr corrected age. Design: We conducted a follow-up study of a cohort of infants born in Scotland from 1999 to 2001 ≤34 wk gestation. Main Outcome Measures: We measured scores on the McCarthy scale adjusted for 26 influences of neurodevelopment including parental intellect, home environment, breast or formula fed, growth retardation, and use of postnatal drugs. Results: A total of 442 infants ≤34 wk gestation who had serum T4 measurements on postnatal d 7, 14, or 28 and 100 term infants who had serum T4 measured in cord blood were followed up at 5.5 yr. Infants with hypothyroxinemia (T4 level ≤ 10th percentile on d 7, 14, or 28 corrected for gestational age) scored significantly lower than euthyroid infants (T4 level greater than the 10th percentile and less than the 90th percentile on all days) on all McCarthy scales, except the quantitative. After adjustment for confounders of neurodevelopment, hypothyroxinemic infants scored significantly lower than euthyroid infants on the general cognitive and verbal scales. Conclusions: Our findings do not support the view that the hypothyroxinemic state, in the context of this analysis, is harmless in preterm infants. Many factors contribute both to the etiology of hypothyroxinemia and neurodevelopment; strategies for correction of hypothyroxinemia should acknowledge its complex etiology and not rely solely on one approach.

AB - Context: Transient hypothyroxinemia is the commonest thyroid dysfunction of premature infants, and recent studies have found adverse associations with neurodevelopment. The validity of these associations is unclear because the studies adjusted for a differing range of factors likely to influence neurodevelopment. Objective: The aim was to describe the association of transient hypothyroxinemia with neurodevelopment at 5.5 yr corrected age. Design: We conducted a follow-up study of a cohort of infants born in Scotland from 1999 to 2001 ≤34 wk gestation. Main Outcome Measures: We measured scores on the McCarthy scale adjusted for 26 influences of neurodevelopment including parental intellect, home environment, breast or formula fed, growth retardation, and use of postnatal drugs. Results: A total of 442 infants ≤34 wk gestation who had serum T4 measurements on postnatal d 7, 14, or 28 and 100 term infants who had serum T4 measured in cord blood were followed up at 5.5 yr. Infants with hypothyroxinemia (T4 level ≤ 10th percentile on d 7, 14, or 28 corrected for gestational age) scored significantly lower than euthyroid infants (T4 level greater than the 10th percentile and less than the 90th percentile on all days) on all McCarthy scales, except the quantitative. After adjustment for confounders of neurodevelopment, hypothyroxinemic infants scored significantly lower than euthyroid infants on the general cognitive and verbal scales. Conclusions: Our findings do not support the view that the hypothyroxinemic state, in the context of this analysis, is harmless in preterm infants. Many factors contribute both to the etiology of hypothyroxinemia and neurodevelopment; strategies for correction of hypothyroxinemia should acknowledge its complex etiology and not rely solely on one approach.

UR - http://www.scopus.com/inward/record.url?scp=78049513299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049513299&partnerID=8YFLogxK

U2 - 10.1210/jc.2010-0743

DO - 10.1210/jc.2010-0743

M3 - Article

C2 - 20719832

AN - SCOPUS:78049513299

VL - 95

SP - 4898

EP - 4908

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 11

ER -